tiprankstipranks
Titan Pharmaceuticals (DE:TN7)
BERLIN:TN7

Titan Pharmaceuticals (TN7) Ownership - Who Owns Titan Pharmaceuticals?

0 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 23, 2023
Lazar David E.
Ceo,director
Sold$4610001
Jan 26, 2023
Lazar David E.
Ceo,director
Bought$56000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
556,317Insider4,161,251
490,262Insider3,667,160
36,144Insider270,357
182,500Insider1,365,100
112,500Insider841,500
102,275Insider765,017
52,690Insider394,121
213,000Insider1,593,240
60Institution449
82,051Institution613,741

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
59,822Institution447,469
82,051Institution613,741

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Titan Pharmaceuticals (DE:TN7)?
Currently, no data Available
What percentage of Titan Pharmaceuticals (DE:TN7) stock is held by institutional investors?
Currently, no data Available
What percentage of Titan Pharmaceuticals (DE:TN7) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Titan Pharmaceuticals (DE:TN7)?
Marc Rubin owns the most shares of Titan Pharmaceuticals (DE:TN7).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis